Macrophage-secreted granulin supports pancreatic cancer metastasis by inducing liver fibrosis.
Sebastian R NielsenValeria QuarantaAndrea LinfordPerpetua EmeagiCarolyn RainerAlmudena SantosLucy IrelandTakao SakaiKeiko SakaiYong-Sam KimDannielle D EngleFiona CampbellDaniel PalmerJeong Heon KoDavid A TuvesonEmilio HirschAinhoa MielgoMichael C SchmidPublished in: Nature cell biology (2016)
Pancreatic ductal adenocarcinoma (PDAC) is a devastating metastatic disease for which better therapies are urgently needed. Macrophages enhance metastasis in many cancer types; however, the role of macrophages in PDAC liver metastasis remains poorly understood. Here we found that PDAC liver metastasis critically depends on the early recruitment of granulin-secreting inflammatory monocytes to the liver. Mechanistically, we demonstrate that granulin secretion by metastasis-associated macrophages (MAMs) activates resident hepatic stellate cells (hStCs) into myofibroblasts that secrete periostin, resulting in a fibrotic microenvironment that sustains metastatic tumour growth. Disruption of MAM recruitment or genetic depletion of granulin reduced hStC activation and liver metastasis. Interestingly, we found that circulating monocytes and hepatic MAMs in PDAC patients express high levels of granulin. These findings suggest that recruitment of granulin-expressing inflammatory monocytes plays a key role in PDAC metastasis and may serve as a potential therapeutic target for PDAC liver metastasis.
Keyphrases
- liver fibrosis
- squamous cell carcinoma
- small cell lung cancer
- dendritic cells
- oxidative stress
- peripheral blood
- induced apoptosis
- stem cells
- adipose tissue
- patient safety
- systemic sclerosis
- papillary thyroid
- climate change
- quality improvement
- young adults
- gene expression
- cell cycle arrest
- human health
- patient reported outcomes